Works matching DE "INTERFERON beta-1a"
Results: 255
Synthesis of Dibenzofuranone-Oxime Derivatives with Anticonvulsant, Antihypoxic, and Anti-Ischemic Activity.
- Published in:
- Pharmaceutical Chemistry Journal, 2020, v. 53, n. 11, p. 997, doi. 10.1007/s11094-020-02112-2
- By:
- Publication type:
- Article
Synthesis and Anticonvulsant Activity of N-Substituted 4-Amino-3-Nitrocoumarins.
- Published in:
- Pharmaceutical Chemistry Journal, 2019, v. 53, n. 2, p. 118, doi. 10.1007/s11094-019-01964-7
- By:
- Publication type:
- Article
Multiple sclerosis patients taking glucagon-like peptide-1 receptor (GLP-1) agonists: a single-institution retrospective cohort study of tolerability and weight loss.
- Published in:
- Neurological Sciences, 2025, v. 46, n. 1, p. 343, doi. 10.1007/s10072-024-07701-7
- By:
- Publication type:
- Article
Long-term fingolimod treatment in two pediatric patients with multiple sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Pegylated interferon beta-1a (Plegridy) Italian real-world experience: a Delphi analysis of injection-site reaction and flu-like symptom management.
- Published in:
- Neurological Sciences, 2021, v. 42, n. 4, p. 1515, doi. 10.1007/s10072-020-04969-3
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers as predictors for disease outcome and functional disability in multiple sclerosis.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2024, v. 70, n. 1, p. 13, doi. 10.33320/maced.pharm.bull.2024.70.01.002
- By:
- Publication type:
- Article
Przyczyny zmiany leczenia immunomodulującego u chorych z postacią rzutowo-remisyjną stwardnienia rozsianego.
- Published in:
- Current Neurology / Aktualno?ci Neurologiczne, 2021, v. 21, n. 1, p. 3, doi. 10.15557/AN.2021.0001
- By:
- Publication type:
- Article
İnterferon Beta-1a İlacının Enzim İnhibisyon Etkilerinin İncelenmesi.
- Published in:
- Journal of the Institute of Science & Technology / Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2022, v. 12, n. 4, p. 2331, doi. 10.21597/jist.1132496
- By:
- Publication type:
- Article
Inhibition of Microglial Activation by Amitriptyline and Doxepin in Interferon-β Pre-Treated Astrocyte–Microglia Co-Culture Model of Inflammation †.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 3, p. 493, doi. 10.3390/brainsci13030493
- By:
- Publication type:
- Article
First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Ultrasound-Guided Biopsy of Pleural-Based Pulmonary Lesions by Injection of Contrast-Enhancing Drugs.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00960
- By:
- Publication type:
- Article
Commentary: Acute Hemorrhagic Leukoencephalitis (Weston--Hurst Syndrome) in a Patient with Relapse-Remitting Multiple Sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Cellular immune responses in multiple sclerosis patients treated with interferon-beta.
- Published in:
- Clinical & Experimental Immunology, 2013, v. 171, n. 3, p. 243, doi. 10.1111/cei.12016
- By:
- Publication type:
- Article
Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Evaluating the Potential Benefit of Interferon Treatment in Multiple Sclerosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 308, n. 3, p. 290, doi. 10.1001/jama.2012.8327
- By:
- Publication type:
- Article
Adherence to self-administering interferon-β1a using RebiSmart® device in Mexican patients with relapsing multiple sclerosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0230959
- By:
- Publication type:
- Article
A multi-center randomized prospective study on the treatment of infant bronchiolitis with interferon α1b nebulization.
- Published in:
- PLoS ONE, 2020, v. 15, n. 2, p. 1, doi. 10.1371/journal.pone.0228391
- By:
- Publication type:
- Article
Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Evidence for a Gender-Specific Protective Role of Innate Immune Receptors in a Model of Perinatal Brain Injury.
- Published in:
- Journal of Neuroscience, 2013, v. 33, n. 28, p. 11556, doi. 10.1523/JNEUROSCI.0535-13.2013
- By:
- Publication type:
- Article
Interferon-β-1a Inhibition of Severe Acute Respiratory Syndrome-Coronavirus 2 In Vitro When Administered After Virus Infection.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Anti-inflammatory and cognitive effects of interferon-β1a (IFNβ1a) in a rat model of Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Manifestation of Susac syndrome during interferon beta-1a and glatiramer acetate treatment for misdiagnosed multiple sclerosis: a case report.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Multiple Sclerosis-like Lesions Induced by Radiation: A Case Report and Systematic Review of the Literature.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 24, p. 7554, doi. 10.3390/jcm13247554
- By:
- Publication type:
- Article
Immunotolerant p50/NFκB Signaling and Attenuated Hepatic IFNβ Expression Increases Neonatal Sensitivity to Endotoxemia.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02210
- By:
- Publication type:
- Article
INEXAS: A Phase 2 Randomized Trial of On‐demand Inhaled Interferon Beta‐1a in Severe Asthmatics.
- Published in:
- Clinical & Experimental Allergy, 2021, v. 51, n. 2, p. 273, doi. 10.1111/cea.13765
- By:
- Publication type:
- Article
MUCE: Bayesian hierarchical modelling for the design and analysis of phase 1b multiple expansion cohort trials.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 2023, v. 72, n. 3, p. 649, doi. 10.1093/jrsssc/qlad025
- By:
- Publication type:
- Article
The Effect of Interferon Beta-1b and Methylprednisolone Treatment on the Serum Trace Elements in Iraqi Patients with Multiple Sclerosis.
- Published in:
- Journal of Clinical & Diagnostic Research, 2012, v. 6, n. 6, p. 994
- By:
- Publication type:
- Article
Evolution of the RebiSmart<sup>®</sup> Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 1923, doi. 10.2147/PPA.S414151
- By:
- Publication type:
- Article
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 1289, doi. 10.2147/PPA.S157317
- By:
- Publication type:
- Article
Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart<sup>®</sup> injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis.
- Published in:
- Patient Preference & Adherence, 2017, v. 11, p. 1189, doi. 10.2147/PPA.S130985
- By:
- Publication type:
- Article
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis.
- Published in:
- Patient Preference & Adherence, 2017, p. 415, doi. 10.2147/PPA.S127508
- By:
- Publication type:
- Article
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects.
- Published in:
- PLoS Neglected Tropical Diseases, 2022, v. 16, n. 8, p. 1, doi. 10.1371/journal.pntd.0010636
- By:
- Publication type:
- Article
Monitoring medication adherence in multiple sclerosis using a novel web-based tool: A pilot study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 7, p. 2024, doi. 10.1111/ene.15314
- By:
- Publication type:
- Article
Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 4, p. 1238, doi. 10.1111/ene.14823
- By:
- Publication type:
- Article
Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 11, p. 3722, doi. 10.1111/ene.15009
- By:
- Publication type:
- Article
Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.
- Published in:
- European Journal of Neurology, 2015, v. 22, n. 7, p. 1113, doi. 10.1111/ene.12716
- By:
- Publication type:
- Article
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
- Published in:
- European Journal of Neurology, 2012, v. 19, n. 10, p. 1311, doi. 10.1111/j.1468-1331.2012.03721.x
- By:
- Publication type:
- Article
A prospective, multi-center, observational study on the use of interferon beta-1a (Rebif) therapy in Egyptian patients with Multiple Sclerosis.
- Published in:
- Egyptian Journal of Hospital Medicine, 2013, v. 50, p. 11, doi. 10.12816/0000821
- By:
- Publication type:
- Article
Induction of CD73 prevents death after emergency open aortic surgery.
- Published in:
- Cardiovascular Research, 2022, v. 118, p. 1, doi. 10.1093/cvr/cvac066.232
- By:
- Publication type:
- Article
The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 1, p. 1, doi. 10.1371/journal.ppat.1005378
- By:
- Publication type:
- Article
The Structure of Classical Swine Fever Virus N<sup>pro</sup>: A Novel Cysteine Autoprotease and Zinc-Binding Protein Involved in Subversion of Type I Interferon Induction.
- Published in:
- PLoS Pathogens, 2013, v. 9, n. 10, p. 1, doi. 10.1371/journal.ppat.1003704
- By:
- Publication type:
- Article